News and Announcements

Tanya Evans, an associate professor, says the notion some people are naturally bad at math doesn’t add up.

A new way of thinking about Alzheimer’s disease has yielded a discovery that could be the key to stopping the cognitive decline seen in Alzheimer’s and other neurodegenerative diseases. University of Virginia School of Medicine scientists have been investigating the possibility that Alzheimer’s is caused, at least in part, by the immune system’s wayward attempts […]

John Lukens directs UVA’s Harrison Family Translational Research Center in Alzheimer’s and Neurodegenerative Diseases and a new study reveals that blocking an immune system molecule in mice prevented memory loss and other signs of mental decline.

Musician Billy Joel recently canceled his concert tour, announcing he will undergo physical therapy for a condition called normal pressure hydrocephalus that is affecting his hearing, vision and balance. UVA Health’s Neurology Department recently opened a clinic to treat the condition, so UVA Today asked the clinic’s Dr. Michael Catalino about the condition, who is vulnerable and how it is treated.

UVA Health researchers are focusing on a surgery-free technique using soundwaves to treat cerebral cavernous malformations.

A new, incision-free technique developed at UVA Health to treat debilitating brain lesions called cerebral cavernous malformations (CCMs) has shown great promise in early testing, halting the growth of the lesions almost entirely. The new approach could represent a paradigm shift in how CCMs are treated, the researchers say. The technique uses tiny, gas-filled “microbubbles” […]

UVA Health scientists are calling for clinical trials testing the potential of HIV drugs called NRTIs to prevent Alzheimer’s disease after discovering that patients taking the drugs are substantially less likely to develop the memory-robbing condition. The researchers, led by UVA’s Jayakrishna Ambati, MD, previously identified a possible mechanism by which the drugs could prevent […]